Annovis Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Annovis Bio, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q3 2021 to Q3 2024.
  • Annovis Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $393K, a 37.8% decline year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $393K -$239K -37.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.6M +$25K +1.59% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $365K -$1.18M -76.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q3 2023 $632K -$1.72M -73.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $1.57M -$332K -17.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.54M -$1.89M -55.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q3 2022 $2.36M +$1.57M +200% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $1.9M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $3.43M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q3 2021 $786K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.